Terms: = Germ cell tumor AND PMS2, HNPCC4, 5395, ENSG00000122512, H_DJ0042M02_9, PMSL2, PMS2CL AND Diagnosis
866 results:
1. Recurrence Patterns and Surveillance Imaging in Pediatric Brain tumor Survivors.
Cacciotti C; Lenzen A; Self C; Pillay-Smiley N
J Pediatr Hematol Oncol; 2024 Apr; 46(3):e227-e232. PubMed ID: 38447113
[TBL] [Abstract] [Full Text] [Related]
2. Hand2 Immunohistochemistry in the diagnosis of Paragangliomas and Other Neuroendocrine Neoplasms.
Soukup J; Manethova M; Stejskal V; Novakova M; Duskova J; Hornychova H; Hacova M; Staniczkova-Zambo I; Zelinka T; Kosak M; Cesak T; Netuka D; Ryska A; Gabalec F
Endocr Pathol; 2024 Mar; 35(1):14-24. PubMed ID: 38416360
[TBL] [Abstract] [Full Text] [Related]
3. Hydrophilic molecularly imprinted resin-hexagonal boron nitride composite as a new adsorbent for selective extraction and determination of a carcinoid tumor biomarker in urine.
Cao J; Wang M; Han Y; Wang M; Yan H
Anal Chim Acta; 2024 Mar; 1294():342289. PubMed ID: 38336412
[TBL] [Abstract] [Full Text] [Related]
4. Pan-cancer analyses of bromodomain containing 9 as a novel therapeutic target reveals its diagnostic, prognostic potential and biological mechanism in human tumours.
Chen Y; Gao Z; Mohd-Ibrahim I; Yang H; Wu L; Fu Y; Deng Y
Clin Transl Med; 2024 Feb; 14(2):e1543. PubMed ID: 38303608
[TBL] [Abstract] [Full Text] [Related]
5. Real-world management practices and characteristics of patients with advanced melanoma initiated on immuno-oncology or targeted therapy in the first-line setting during the period 2015-2018 in Greece. The 'SUMMER' study: a retrospective multicenter chart review project.
Bafaloukos D; Kouzis P; Gouveris P; Boukovinas I; Kalbakis K; Baka S; Kyriakakis G; Moschou D; Molfeta A; Demiri S; Mavroudis D; Spanoudi F; Dimitriadis I; Gogas H
Melanoma Res; 2024 Apr; 34(2):152-165. PubMed ID: 38092014
[TBL] [Abstract] [Full Text] [Related]
6. Multidisciplinary neurofibromatosis conference in the management of patients with neurofibromatosis type 1 and schwannomatosis in a single tertiary care institution.
Debs P; Belzberg A; Blakeley J; Fayad L; Langmead S; Little E; Romo C; Schatz K; Slobogean B; Ahlawat S
Skeletal Radiol; 2024 May; 53(5):909-916. PubMed ID: 37950060
[TBL] [Abstract] [Full Text] [Related]
7. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System tumors Diagnosed in the United States in 2016-2020.
Ostrom QT; Price M; Neff C; Cioffi G; Waite KA; Kruchko C; Barnholtz-Sloan JS
Neuro Oncol; 2023 Oct; 25(12 Suppl 2):iv1-iv99. PubMed ID: 37793125
[TBL] [Abstract] [Full Text] [Related]
8. Laser Interstitial Thermal Therapy Induces Robust Local Immune Response for Newly Diagnosed Glioblastoma With Long-term Survival and Disease Control.
Chandar JS; Bhatia S; Ingle S; Mendez Valdez MJ; Maric D; Seetharam D; Desgraves JF; Govindarajan V; Daggubati L; Merenzon M; Morell A; Luther E; Saad AG; Komotar RJ; Ivan ME; Shah AH
J Immunother; 2023 Nov-Dec 01; 46(9):351-354. PubMed ID: 37727953
[TBL] [Abstract] [Full Text] [Related]
9. Survival and neurological outcomes after stereotactic biopsy of diffuse intrinsic pontine glioma: a systematic review.
Dalmage M; LoPresti MA; Sarkar P; Ranganathan S; Abdelmageed S; Pagadala M; Shlobin NA; Lam S; DeCuypere M
J Neurosurg Pediatr; 2023 Dec; 32(6):665-672. PubMed ID: 37724839
[TBL] [Abstract] [Full Text] [Related]
10. Glioma genetic profiles associated with electrophysiologic hyperexcitability.
Tobochnik S; Dorotan MKC; Ghosh HS; Lapinskas E; Vogelzang J; Reardon DA; Ligon KL; Bi WL; Smirnakis SM; Lee JW
Neuro Oncol; 2024 Feb; 26(2):323-334. PubMed ID: 37713468
[TBL] [Abstract] [Full Text] [Related]
11. germline pathogenic variants in neuroblastoma patients are enriched in BARD1 and predict worse survival.
Kim J; Vaksman Z; Egolf LE; Kaufman R; Evans JP; Conkrite KL; Danesh A; Lopez G; Randall MP; Dent MH; Farra LM; Menghani NL; Dymek M; Desai H; Hausler R; Hicks B; Auvil JG; Gerhard DS; Hakonarson H; Maxwell KN; Cole KA; Pugh TJ; Bosse KR; Khan J; Wei JS; Maris JM; Stewart DR; Diskin SJ
J Natl Cancer Inst; 2024 Jan; 116(1):149-159. PubMed ID: 37688579
[TBL] [Abstract] [Full Text] [Related]
12. A single center case series of immune checkpoint inhibitor-induced type 1 diabetes mellitus, patterns of disease onset and long-term clinical outcome.
Marsiglio J; McPherson JP; Kovacsovics-Bankowski M; Jeter J; Vaklavas C; Swami U; Grossmann D; Erickson-Wayman A; Soares HP; Kerrigan K; Gibson B; Doherty JA; Hyngstrom J; Hardikar S; Hu-Lieskovan S
Front Immunol; 2023; 14():1229823. PubMed ID: 37671166
[TBL] [Abstract] [Full Text] [Related]
13. Long-term survival in patients with brain metastases-clinical characterization of a rare scenario.
Hügel M; Stöhr J; Kuhnt T; Nägler F; Papsdorf K; Klagges S; Hambsch P; Güresir E; Nicolay NH; Seidel C
Strahlenther Onkol; 2024 Apr; 200(4):335-345. PubMed ID: 37646818
[TBL] [Abstract] [Full Text] [Related]
14. Management and Long-term Outcomes of Adults With Medulloblastoma: A Single-Center Experience.
Neth BJ; Raghunathan A; Kizilbash SH; Uhm JH; Breen WG; Johnson DR; Daniels DJ; Sener U; Carabenciov ID; Campian JL; Khatua S; Mahajan A; Ruff MW
Neurology; 2023 Sep; 101(12):e1256-e1271. PubMed ID: 37524533
[TBL] [Abstract] [Full Text] [Related]
15. A reinforcement learning model for AI-based decision support in skin cancer.
Barata C; Rotemberg V; Codella NCF; Tschandl P; Rinner C; Akay BN; Apalla Z; Argenziano G; Halpern A; Lallas A; Longo C; Malvehy J; Puig S; Rosendahl C; Soyer HP; Zalaudek I; Kittler H
Nat Med; 2023 Aug; 29(8):1941-1946. PubMed ID: 37501017
[TBL] [Abstract] [Full Text] [Related]
16. Fibroblast Activation Protein Targeting Probe with Gly-Pro Sequence for PET of Glioblastoma.
Lai C; Cao R; Li R; He C; Wang X; Shi H; Qu C; Qian K; Song S; Chen WH; Cheng Z
Mol Pharm; 2023 Aug; 20(8):4120-4128. PubMed ID: 37487027
[TBL] [Abstract] [Full Text] [Related]
17. Early-Onset Pancreatic Neuroendocrine tumors: Clinical Presentation, Pathology Features, and Oncological Outcomes.
Pulvirenti A; Hauser HF; Fiedler LM; McIntyre CA; Le T; Reidy-Lagunes DL; Soares KC; Balachandran VP; Kingham TP; D'Angelica MI; Drebin JA; Jarnagin WR; Raj N; Wei AC
Ann Surg; 2024 Jan; 279(1):125-131. PubMed ID: 37325926
[TBL] [Abstract] [Full Text] [Related]
18. Risk of Mortality After a diagnosis of Melanoma In Situ.
Patel VR; Roberson ML; Pignone MP; Adamson AS
JAMA Dermatol; 2023 Jul; 159(7):703-710. PubMed ID: 37285145
[TBL] [Abstract] [Full Text] [Related]
19. Long-term survival with IDH wildtype glioblastoma: first results from the ETERNITY Brain tumor Funders' Collaborative Consortium (EORTC 1419).
Hertler C; Felsberg J; Gramatzki D; Le Rhun E; Clarke J; Soffietti R; Wick W; Chinot O; Ducray F; Roth P; McDonald K; Hau P; Hottinger AF; Reijneveld J; Schnell O; Marosi C; Glantz M; Darlix A; Lombardi G; Krex D; Glas M; Reardon DA; van den Bent M; Lefranc F; Herrlinger U; Razis E; Carpentier AF; Phillips S; Rudà R; Wick A; Tabouret E; Meyronet D; Maurage CA; Rushing E; Rapkins R; Bumes E; Hegi M; Weyerbrock A; Aregawi D; Gonzalez-Gomez C; Pellerino A; Klein M; Preusser M; Bendszus M; Golfinopoulos V; von Deimling A; Gorlia T; Wen PY; Reifenberger G; Weller M
Eur J Cancer; 2023 Aug; 189():112913. PubMed ID: 37277265
[TBL] [Abstract] [Full Text] [Related]
20. Comparison of quantitative FDG-PET and MRI in anti-LGI1 autoimmune encephalitis.
Sadaghiani MS; Roman S; Diaz-Arias LA; Habis R; Venkatesan A; Probasco JC; Solnes LB
Neuroradiology; 2023 Aug; 65(8):1225-1238. PubMed ID: 37264220
[TBL] [Abstract] [Full Text] [Related]
[Next]
